The CPAP Paradox — Fixed Apnea, Still Exhausted

A passenger sleeping on an airplane with headphones and an eye mask

Sleep apnea treatment can fix breathing at night and still leave some people dragging through the day.

Quick Take

Persistent sleepiness after continuous positive airway pressure therapy is a real and documented problem.
Studies put the rate at about 9 to 22 percent after adequate treatment, with higher rates early on.
Common causes include poor adherence, mask leaks, wrong pressure settings, and other sleep disorders.
Some patients also have lingering brain and nerve effects from past sleep disruption.

What Patients Notice After Treatment

Many people expect continuous positive airway pressure therapy, or CPAP, to end the exhaustion as soon as the mask goes on. That often happens. But a meaningful minority still report excessive daytime sleepiness even when treatment appears to be working.

The pattern matters because this is not the same as untreated sleep apnea. In these cases, breathing may improve while the person still feels foggy, heavy, and slow to wake. The problem can show up early, especially in the first three months, and then ease over time for many patients.

Why Sleepiness Can Linger

The first place clinicians look is the CPAP setup itself. Poor mask fit, air leaks, the wrong pressure, and not using the machine long enough can all leave sleep fragmented and symptoms unresolved. Dr. Vintch, cited in a sleep medicine article, called poor adherence the number one reason people stay sleepy despite treatment.

When the machine is not the full answer, doctors look for other causes that were hiding in plain sight. Studies point to depression, diabetes, heart disease, lower initial sleepiness scores, restless legs, periodic limb movements, and behaviorally induced sleep loss as common contributors. One review found that after excluding other explanations, only about 6 percent had truly unexplained residual sleepiness.

What the Research Suggests About the Body and Brain

There is also a deeper story here. Research has linked obstructive sleep apnea to chronic intermittent low oxygen and repeated sleep disruption, both of which may injure wake-promoting brain circuits. That helps explain why some people improve in breathing numbers but not in how alert they feel.

One major review found residual excessive daytime sleepiness in about 9 to 22 percent of patients despite adequate primary therapy. A separate study reported about 40 percent during the first three months, dropping to 10 to 20 percent after that. The timing matters, because some patients simply need more time before the brain and body settle down.

New research reveals that chronic snoring can cause brain damage — and contribute to dementia.

Loud, persistent snoring is often the primary indicator of Obstructive Sleep Apnea (OSA), a condition where breathing repeatedly stops and starts throughout the night.

These… pic.twitter.com/cWguhGW9Za

— Shining Science (@ShiningScience) July 8, 2026

That does not mean CPAP failed. It means the diagnosis was only part of the problem. A person can still have insomnia, narcolepsy, restless legs syndrome, depression, thyroid trouble, or another medical issue that keeps the fatigue alive even after apnea events are better controlled.

Why This Problem Gets Missed

Residual sleepiness is easy to undercount because patients and clinicians often focus on the apnea index, not daily function. Yet the lived problem is plain: a person can use CPAP, breathe better, and still struggle to stay awake at work or behind the wheel.

That gap between technical success and real-world relief is why follow-up matters. Sleep specialists often want to confirm actual CPAP use, check for leaks and pressure problems, review medicines, and screen for other sleep disorders before calling the case “treated”.

What Comes Next for Patients and Doctors

The smartest next step is not guessing. It is a careful check of adherence, sleep duration, comorbid illness, and other sleep disorders. If those factors do not explain the problem, some patients may be candidates for wake-promoting medicine after a period of stable CPAP use, as the Food and Drug Administration notes in consumer guidance on persistent sleepiness.

The bigger lesson is simple. CPAP can be life-changing and still leave a stubborn minority tired. That is not a contradiction. It is a reminder that sleep apnea often comes with more than one problem, and the fix has to match the full picture.